News |

Shore Capital appointed to provide Corporate Access and Research Services to Savannah Petroleum plc

Shore Capital is pleased to have been appointed to provide Corporate Access and Research Services to Savannah Petroleum (AIM: SVAP). […]

 

News |

Big pharma model is being challenged

Shore Capital Healthcare Analyst, Tara Raveendran, discusses how innovation, coming from small and mid-cap companies, is challenging big pharma on […]

 

News |

Life Science Analysis: What does Roche’s takeover of Flatiron Health mean?

With Roche being particularly active on the real-world-data front with its recent acquisition of the US cancer data analytics firm […]

 

News |

Technology Conference

  The Technology Conference is being organised by Shore Capital Stockbrokers Limited. We have considered that the event, based on […]

 

News |

Shore Capital Appointed Joint Broker to Sirius Minerals Plc

    Shore Capital is pleased to have been appointed as joint broker to Sirius Minerals Plc (Premium: SXX). Sirius […]

 

SCGL Director/PDMR Shareholding

Shore Capital Group Limited (“Shore Capital” or the “Company”) Director/PDMR Shareholding Shore Capital was notified today that David Kaye, a […]

 

SCGL Director/PDMR Shareholding

Shore Capital Group Limited (“Shore Capital” or the “Company”) Director/PDMR Shareholding Shore Capital was notified today that David Kaye, a […]

 

News |

Shore Capital’s Kevin MacDonald wins the Mudlark Award for Exceptional Performance in the Back Office

We’re delighted to announce that Kevin MacDonald, Head of Operations at Shore Capital, has won the Mudlark Award for ‘Exceptional […]

 

SCGL Performance of Funds – February 2018

The following table gives the performance for the month ended 28 February 2018 of the funds managed by the Group’s […]

 

News |

Preliminary Results for the Year Ended 31 December 2017

Strong Group performance with significant growth in revenues and profitability Shore Capital, the independent investment group specialising in capital markets, […]

 

News |

Shore Capital acts as Sole Bookrunner: Successful Completion of Placing to Raise £12m for Yu Group

   Yü Group PLC (the “Group” or “Company”)   Successful completion of placing to raise £12.0 million  Yü Group PLC […]

 

News |

Northern Ireland – is the stock market right for you?

Northern Ireland has a very good seam of entrepreneurs, it has been producing great business folks for many generations, some […]

 

SCGL Performance of Funds – January 2018

The following table gives the performance for the month ended 31 January 2018 of the funds managed by the Group’s […]

 

News |

Shore Capital appointed Nominated Adviser and Sole Broker to Produce Investments Plc

  Produce Investments Plc – Change of Broker Produce Investments plc (AIM: PIL), a leading operator in the fresh potato […]

 

News |

Shore Capital Healthcare Conference – Session Highlights

On the morning of Wednesday, the 28th of February Shore Capital hosted its inaugural healthcare conference focussed on Orphan and […]

 

News |

Speakers announced for Shore Capital Healthcare Conference

Please note that this Conference is considered by Shore Capital to be an acceptable minor non-monetary benefit under COBS 2.3A.19 […]

 

News |

Shore Capital talks Irish grocery at the Checkout Retail Conference

Shore Capital’s Head of Research, Dr Clive Black, will be comparing and contrasting the Irish and UK retail markets at […]

 

News |

Living in the Listed World

Shore Capital Markets joins with Deloitte to try and demystify the IPO process for growth companies in Northern Ireland. Head […]

 

News |

Shore Capital Appointed as Nominated Adviser and Sole Broker to Oxford BioDynamics Plc

Shore Capital has been appointed with immediate effect as Nominated Adviser and Sole Broker to Oxford BioDynamics Plc      […]

 

SCGL Performance of Funds – December 2017

The following table gives the performance for the month ended 31 December 2017 of the funds managed by the Group’s […]

 

Our website uses necessary cookies in order for it to run. We would also like to use optional analytics cookies to improve the site, by collecting and reporting information on how you use it. These cookies do not directly identify the user and won’t set optional cookies unless they are accepted. For more information on how our site cookies work, please see our Privacy Policy.